adjuvant exemestane more effective than tamoxifen (combined with ofs) in women with breast cancer
Published 10 years ago • 1.6K plays • Length 6:13Download video MP4
Download video MP3
Similar videos
-
5:44
breast cancer: adjuvant exemestane combined with ovarian function suppression better than tamoxifen
-
10:05
gs2-05: "randomized comparison of adjuvant aromatase inhibitor exemestane (e) plus ovarian..."
-
5:39
ductal carcinoma in situ: anastrozole versus tamoxifen
-
3:37
comparing adjuvant tamoxifen with ovarian function suppression via exomestane to tamoxifen alone
-
5:31
her2 status as predictive marker for aromatase inhibitor versus tamoxifen use in early breast cancer
-
5:46
adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for her2-positive breast cancer
-
1:13
dr. pagani discusses aromatase inhibitors for premenopausal women with breast cancer
-
6:32
no significant difference in recurrence rates among women with dcis taking anastrozole or tamoxifen
-
4:02
low-dose tamoxifen as effective as higher doses for breast cancer patients
-
2:47
adjuvant endocrine therapy in premenopausal breast cancer: 12-year results from soft
-
0:27
how to cope with tamoxifen and letrozole
-
3:39
comparable outcomes, different toxicities with anastrozole, tamoxifen in dcis | ivana sestak
-
4:54
adjuvant hormonal therapy for estrogen receptor positive early stage breast cancer - mayo clinic
-
6:57
anastrozole vs. letrozole for breast cancer: which aromatase inhibitor is the best?
-
4:38
anastrozole offers higher breast cancer-free survival rates than tamoxifen following dcis
-
4:57
low dose exemestane usage in breast cancer
-
0:31
should your breast cancer be treated with tamoxifen? #breastcancer #tamoxifen #drlizexplains
-
1:12
dr. joseph sparano on the role of endocrine therapy in breast cancer
-
0:07
if you're on tamoxifen, letrozole, anastrozole or exemestane...you need to know this...